- Home
- VALN vs AXG Comparison
VALN vs AXG Comparison
Compare VALN & AXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VALN | AXG |
|---|---|---|
| Founded | 2012 | 2021 |
| Country | France | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 855.8M | 790.2M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | VALN | AXG |
|---|---|---|
| Price | $10.30 | $4.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.75 | N/A |
| AVG Volume (30 Days) | 19.5K | ★ 716.8K |
| Earning Date | 11-20-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $211,089,992.00 | $7,656,000.00 |
| Revenue This Year | $3.64 | $28.53 |
| Revenue Next Year | $12.23 | $54.60 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.48 | ★ 216.49 |
| 52 Week Low | $4.56 | $1.16 |
| 52 Week High | $12.25 | $5.09 |
Technical Indicators
Market Signals| Indicator | VALN | AXG |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | N/A |
| Support Level | $9.62 | N/A |
| Resistance Level | $10.32 | N/A |
| Average True Range (ATR) | 0.30 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 62.50 | 0.00 |
Price Performance
Historical ComparisonAbout VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About AXG Solowin Holdings Class A Ordinary Share
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.